Active — Not RecruitingNot Applicable

Remote Monitoring of CGM Data in Pediatric Patients With Newly Diagnosed Type 1 Diabetes (T1D)

United States100 participantsStarted 2019-03-25

Plain-language summary

To determine if increased targeted contact between patients and the care team can improve diabetes outcomes in the 1st year after diagnosis. We will be using the GluVue platform to remotely view continuous glucose monitor (CGM) data.

Who can participate

Age range6 Months – 21 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All individuals within one month of T1D diagnosis seen at the Stanford Children's Diabetes Clinic * Individuals who plan to receive follow up care at the Stanford Children's Diabetes Clinic * Individuals who agree to CGM data integration into the electronic medical record (EMR) for remote monitoring * Age: birth to \< 21 years of age Exclusion Criteria: * Diabetes diagnosis other than T1D * Diagnosis of diabetes \> 1 month prior to initial visit * Individuals with the intention of obtaining diabetes care at another clinic * Individuals who do not consent to CGM use, CGM data integration, or remote monitoring * Individuals \> 21 years of age

What they're measuring

Contacts with the care provider

Timeframe: 1 year

Trial details

NCT IDNCT03968055

SponsorStanford University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-30

View on ClinicalTrials.gov More Type 1 Diabetes trials